Initial Workup for Pruritus
For patients presenting with generalized pruritus without an obvious dermatologic cause, obtain a focused laboratory panel including complete blood count with ferritin, liver function tests, urea and electrolytes, and perform a comprehensive medication review. 1, 2
History and Physical Examination
Key Historical Elements to Obtain
- Onset, duration, and distribution of itching (generalized vs. localized, palms/soles involvement suggests cholestasis) 1
- Presence or absence of rash (primary skin lesions indicate dermatologic disease; excoriations alone suggest systemic cause) 1
- Timing patterns (worse at night suggests cholestasis or scabies) 1
- Complete medication list including over-the-counter drugs, opioids, and recent additions (drug-induced pruritus is common and reversible) 1, 2
- Travel history, sexual history, IV drug use (assess HIV, hepatitis, parasitic infection risk) 1
- Associated symptoms: weight loss, fatigue, jaundice, dark urine, fever, changes in bowel habits 1, 3
- Personal or family history of atopy (eczema, asthma, allergic rhinitis) 1
Physical Examination Focus
- Complete skin examination including scalp, finger webs, anogenital region, and nails 4, 5
- Distinguish primary vs. secondary lesions (primary lesions = diseased skin; secondary lesions = scratching effects) 4
- Assess for jaundice, lymphadenopathy, hepatosplenomegaly 1, 3
- Evaluate for excoriations, prurigo nodularis (suggest chronic scratching without underlying rash) 1
Initial Laboratory Workup
Essential First-Line Tests
Order these tests for all patients with chronic generalized pruritus without obvious dermatologic cause: 1, 2
- Complete blood count with differential and ferritin (screens for iron deficiency, polycythemia vera, eosinophilia, hematologic malignancies) 1, 2
- Liver function tests (evaluate hepatic causes; consider adding bile acids and antimitochondrial antibodies if liver disease suspected) 1, 2
- Urea and electrolytes/renal function (assess for uremic pruritus) 1, 2
- Fasting glucose or HbA1c (screen for diabetes) 4, 5
Additional Testing Based on Clinical Suspicion
- HIV and hepatitis B/C serology if risk factors present (IV drug use, sexual history, travel) 1, 2
- Thyroid-stimulating hormone only if clinical features suggest thyroid disease (do NOT order routinely) 1, 2
- Lactate dehydrogenase, blood film, ESR if hematologic malignancy suspected 1
- JAK2 V617F mutation if polycythemia vera suspected (elevated hemoglobin/hematocrit) 1
- Chest X-ray if lymphoma or other malignancy suspected based on symptoms 1, 3
What NOT to Do (Common Pitfalls)
- Do not order routine thyroid function tests without clinical features suggesting endocrinopathy 1, 2
- Do not pursue extensive malignancy screening in the absence of specific systemic symptoms (thorough history and physical examination sufficient initially) 1, 2
- Do not overlook medication review as a reversible cause 1, 2
- Do not use sedating antihistamines in elderly patients (except palliative care) due to dementia risk 1, 2
Special Population: Elderly Patients
Before pursuing extensive workup in elderly patients, initiate a 2-week trial of emollients with high lipid content and topical steroids to exclude asteatotic eczema (dry skin). 1, 2 This common condition can mimic systemic pruritus and responds to simple measures. 1, 2
Initial Management While Awaiting Results
- Emollients (liberal use, high lipid content preferred in elderly) 1, 2
- Non-sedating antihistamines (short trial as second-line) 2
- Topical doxepin or clobetasone butyrate/menthol preparations 2
- Trial cessation of potentially causative medications when risk-benefit acceptable 1, 2
When to Refer
- Hematology referral: suspected polycythemia vera or lymphoma 1, 2
- Hepatology referral: any suggestion of significant hepatic impairment 1, 2
- Dermatology referral: diagnostic doubt, persistent symptoms despite primary care management, consideration of skin biopsy for cutaneous lymphoma 1, 2
Heightened Malignancy Concern
Maintain heightened suspicion for underlying malignancy in patients over 60 years with diffuse pruritus of less than 12 months duration, especially with history of liver disease. 5 However, do not pursue full malignancy workup routinely without specific systemic symptoms. 1, 2